EP2931425A1 - Manipulation der grösse von flüssigkeitströpfchen in digitaler mikrofluidik - Google Patents
Manipulation der grösse von flüssigkeitströpfchen in digitaler mikrofluidikInfo
- Publication number
- EP2931425A1 EP2931425A1 EP13770655.2A EP13770655A EP2931425A1 EP 2931425 A1 EP2931425 A1 EP 2931425A1 EP 13770655 A EP13770655 A EP 13770655A EP 2931425 A1 EP2931425 A1 EP 2931425A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- electrode
- liquid droplet
- container
- polymer film
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 274
- 238000012545 processing Methods 0.000 claims abstract description 95
- 239000000758 substrate Substances 0.000 claims abstract description 35
- 230000001939 inductive effect Effects 0.000 claims abstract description 5
- 239000012472 biological sample Substances 0.000 claims description 107
- 229920006254 polymer film Polymers 0.000 claims description 76
- 239000003153 chemical reaction reagent Substances 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 230000002209 hydrophobic effect Effects 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 10
- 238000006073 displacement reaction Methods 0.000 claims description 7
- 238000004026 adhesive bonding Methods 0.000 claims description 5
- 238000003466 welding Methods 0.000 claims description 5
- 239000010408 film Substances 0.000 description 33
- 239000000523 sample Substances 0.000 description 25
- 239000013615 primer Substances 0.000 description 22
- 239000002987 primer (paints) Substances 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 238000012163 sequencing technique Methods 0.000 description 15
- 230000006037 cell lysis Effects 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 239000011324 bead Substances 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 230000005661 hydrophobic surface Effects 0.000 description 9
- 238000003491 array Methods 0.000 description 8
- 239000004020 conductor Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 230000009089 cytolysis Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108020005196 Mitochondrial DNA Proteins 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000012777 electrically insulating material Substances 0.000 description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000005499 meniscus Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000013355 Mycteroperca interstitialis Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- -1 SNP Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002844 continuous effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
- B01L3/502792—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics for moving individual droplets on a plate, e.g. by locally altering surface tension
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5029—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures using swabs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
- B01L2200/027—Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0819—Microarrays; Biochips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0409—Moving fluids with specific forces or mechanical means specific forces centrifugal forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0427—Electrowetting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/02—Burettes; Pipettes
- B01L3/0241—Drop counters; Drop formers
- B01L3/0268—Drop counters; Drop formers using pulse dispensing or spraying, eg. inkjet type, piezo actuated ejection of droplets from capillaries
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/52—Containers specially adapted for storing or dispensing a reagent
- B01L3/527—Containers specially adapted for storing or dispensing a reagent for a plurality of reagents
Definitions
- the present invention relates to manipulating the size of liquid droplets in digital microfluidics.
- This technical field generally relates to the control and manipulation of liquids in a small volume, usually in the micro- or nanoscale format. Movement of small liquid volumes in a channel system is known per se as, e.g . being controlled by micro pumps in stationary devices or centripetal forces in rotating lab- ware.
- a defined voltage is applied to electrodes of an electrode array, so that individual droplets are addressed by electrowetting .
- electrowetting method please see Washizu, IEEE Transactions on Industry Applications, Volume 34, No. 4, 1998, and Pollack et al ., Lab chip, 2002, Volume 2, 96-101.
- electrowetting refers to a method to move liquid droplets using arrays of microelectrodes, preferably covered by a dielectric layer that comprises a hydrophobic surface.
- a defined voltage By applying a defined voltage to selected electrodes of the electrode array, a change of the surface tension of the liquid droplet, which is present on the hydrophobic surface above the addressed electrodes, is induced. This results in a remarkable change of the contact angle of the droplet on the addressed electrode, hence in a lateral movement of the droplet.
- two principle ways to arrange the electrodes are known : using one single surface with an electrode array for inducing the movement of droplets or adding a second surface that is opposite a similar electrode array and that provides at lest one ground electrode.
- a major advantage of the electrowetting technology is that only a small volume of liquid is required, e.g . a single droplet.
- liquid processing can be carried out within considerably shorter time.
- control of the liquid movement can be completely under electronic control resulting in automated processing of samples.
- a device for liquid droplet manipulation by electrowetting using one single surface with an electrode array (a monoplanar arrangement of electrodes) is known from the US patent No. 5,486,337. All electrodes are placed on a surface of a carrier substrate, lowered into the substrate, or covered by a non-wettable surface. A voltage source is connected to the electrodes. The droplet is moved by applying a voltage to subsequent electrodes, thus guiding the movement of the liquid droplet above the electrodes according to the sequence of voltage application to the electrodes. Dispensing of a droplet is disclosed by an electrostatic pipette that consists of a non-wettable tube adjacent to a tubular wettable primary electrode exposed to a source of sample liquid .
- Annular, non-wettable secondary electrodes are spaced axially along the non-wettable tube from the primary electrode, into which the sample liquid enters by capillary action. Voltage is sequentially applied between primary electrode and secondary electrodes along the non-wettable tube. Conse- quently, a portion of the sample liquid is electrostatically charged by the primary electrode and then attracted in the form of a charged droplet by the consecutive secondary electrodes.
- An apparatus with a single-sided electrode design for manipulating droplets is also known from US 6,911,132 B2, all conductive elements being contained on a first surface on which droplets are manipulated .
- An additional surface can be provided parallel with the first surface for the purpose of containing the droplets to be manipulated .
- the apparatus enables droplet manipulating such as merging and mixing two droplets together, splitting a droplet into two or more droplets, sampling a con- tinuous liquid flow by forming from the flow individually controlled droplets, and iterative binary or digital mixing of droplets to obtain a desired mixing ratio. Merging is performed using at least three aligned drive electrodes that initially are switched off, the first and third electrode each bearing a drop of liquid on top of the surface covering it.
- An electrowetting device for microscale control of liquid droplet movements, using and electrode array with an opposing surface with at least one ground electrode of is known from US 6,565,727 (a biplanar arrangement of electrodes). Each surface of this device may comprise a plurality of electrodes.
- the drive electrodes of the electrode array are preferably arranged in an interdigitated relationship (see also US 6,911,132 B2) with each other by projections located at the edges of each single electrode.
- the two opposing arrays form a gap.
- the surfaces of the electrode arrays directed towards the gap are preferably covered by an electrically insulating, hydrophobic layer.
- the liquid droplet is positioned in the gap and moved within a non-polar filler fluid by consecutively applying a plurality of electric fields to a plurality of electrodes positioned on the opposite sites of the gap.
- a drop meter with larger area defined by a hydrophobic surface of a control pad is connected via a small extension to a path or driveway of drive electrodes, the first one being a cutoff electrode and the second one being a control electrode.
- a wetting potential is first applied to the cutoff electrode, the liquid which has covered the surface of the control pad thus spreading over the cutoff and drive electrodes. Consequently, the wetting potential is removed from the cutoff electrode, making it hydrophobic again. Part of the liquid moves back to the contact pad ad is replaced by the non- polar filler fluid.
- a container with a polymer film for manipulating samples in liquid droplets thereon is known from WO 2010/069977 Al .
- the polymer film is placed onto a liquid drop- let manipulation instrument that comprises an electrode array and is kept at a distance to a base side of the container thus creating a gap where the manipulation of samples in liquid droplets takes place. Separation of a liquid droplet from a liquid portion that covers several electrodes is performed by drive voltage pulses applied to subsequent drive electrodes leading away a separated liquid droplet from the liq- uid portion.
- WO 2010/040227 Al is known a hybrid digital and channel microfluidic device in the form of an integrated structure in which a liquid droplet may be transported by a digital microfluidics array and transferred to a microfluidic channel. Merging two liquid separate droplets by moving them on two separated driveway and then joining these electrode paths is also disclosed.
- This ob- ject is achieved according to a first aspect by a liquid droplet manipulation instrument as herein described and disclosed .
- This object is achieved according to a second aspect by a biological sample processing system as herein described and disclosed.
- the system provides a multi-component device adjusted for a fully automated processing of biological samples up to the analysis.
- Such a fully integrated system that can directly accept macro-volumes of sample (either in liquid form or on a solid surface such as a buccal swab) and process utilizing nano-volumes; all without any user interaction.
- a feature of this invention is that small aliquots of reagents can be manipulated from a larger starting volume. This allows large, arbitrary amounts of fluid to be introduced to the cartridge (by a user or an instrument) without a requirement for high precision. This further allows the device to be used by a larger range of users, including ones that cannot add precise volumes and/or to be made less expensively.
- Figure 1 a schematic cross section and partial layout of a biological sample proc- essing system according to the first aspect of the present invention
- Figure 2 a top view on a container and a film of a biological sample processing system according to the present invention, wherein :
- Fig. 2A shows the at least one well for positioning the biological sample being arranged towards the outer margin of the container
- Fig. 2B shows the at least one well for positioning the biological sample being arranged in the center of the container;
- Figure 3 top views of different embodiments of preferred electrode arrays, wherein in :
- each electrode is accomplished in form of a rectangle; Fig. 3B each electrode is accomplished in form of a hexagon; Fig. 3C each electrode is accomplished in form of a circle; and Fig. 3D each electrode is accomplished in form of a triangle.
- FIG. 4 top views of a grid-like electrode array according to a first preferred embodiment and similar to the array of Fig. 3A with rectangular electrodes, wherein in :
- a liquid portion of a larger volume covers about 18 pulsed drive electrodes of the same electrode array
- Fig . 4B a group of two electrodes identical with previously pulsed drive electrodes are provided with a ground voltage pulse
- Fig . 4C a group of three electrodes identical with previously pulsed drive electrodes are provided with a ground voltage pulse
- FIG. 5 top views of a grid-like electrode array according to a second preferred embodiment and similar to the array of Fig . 3A with rectangular electrodes, wherein in :
- a liquid portion of a larger volume covers about 6 pulsed drive electrodes of the same electrode array
- FIG. 6 top views of a grid-like electrode array according to a third preferred embodiment and similar to the array of Fig. 3A with rectangular electrodes and an electrode path adjacent to the array, wherein in : Fig . 6A a liquid portion of a larger volume covers about 10 activated electrodes of the electrode array;
- the third drive electrode of the electrode path is activated, the first two adjacent drive electrodes are inactivated and a group of 9 electrodes of the electrode array are activated, the remaining liquid portion now covering about 9 electrodes of the electrode array;
- the fourth drive electrode of the electrode path is activated, the second and third drive electrodes are inactivated, and the first drive electrode of the electrode path is activated together with adjacent 9 electrodes of the electrode array, three electrodes of the electrode array are inactivated;
- the fifth drive electrode of the electrode path is activated, the fourth drive electrode is inactivated, and the first three drive electrodes of the electrode path are activated, all electrodes of the electrode array are inactivated;
- the fifth drive electrode of the electrode path is activated and the fourth drive electrode is inactivated
- the third drive electrode of the electrode path is activated together with 6 electrodes of the array
- the first two drive electrodes of the electrode path are inactivated together with 6 electrodes of the array, the re- maining liquid portion now covering about 8 electrodes of the electrode array.
- Figure 1 shows a schematic cross section and partial layout of an exemplified biological sample processing system 1 according to the first aspect of the present invention.
- this system 1 comprises distinct single components which can be assembled to one unit, the system 1, in simple steps.
- Such component is fo example a container 2 which is comprised by the biological sample processing sys- tem 1.
- the container 2 is accomplished for processing large volumes of liquid 18.
- large volumes of liquid are understood to relate to liquid volumes up to 5 ml or up to 10 ml, depending on the sample to be hosted.
- the large volume well is pref- erably designed to hold volumes up to 2 ml; if holding for example whole blood, the well preferably holds up to 5 ml .
- the container 2 has a top side 3 and a base side 4. At its base side 4, the container 2 comprises protrusions 5. These protrusions 5 may be accomplished as parts of the container 2 extending downwardly at the base side 4. Alternatively these protrusions 5 may be attached to the base side 4 of the container 2 separately, for example by gluing, welding or other appropriate means to stably attach such protrusions 5 to the base side 4 of the container 2.
- the container 2 comprises at least one well 6. This at least one well 6 is open at its top side 7.
- a biological sample 9, a reaction reagent 10, or both can be positioned within this well 6.
- the at least one well 6 has at least one opening 11. This opening is connected by a channel 12 of the container 2 with an orifice 13 of the container 2 at its base side 4.
- a liquid 18 or a liquid droplet 19 is placed into the at least one well 6 (with or without a reaction reagent, and/or with or without at least parts of the biological sample 9), it can be transferred out of the well 6 through the channel 12.
- the diameter of the channel 12 preferably is chosen such that the capillary force prevents liquid from leaking out the orifice 13 and that the liquids thus stay inside the at least one well 6 without need for a valve or any other closure of the channel 12.
- the diameter of the channel 12 preferably is from 100 prn to 1 mm.
- the biological sample processing system 1 comprises a flat polymer film 14.
- This flat polymer film 14 could also be called a "plastic skin” as proposed by Yang et al. (2008) “Exchangeable, pre-loaded "Skin Depot” for digital microfluidics” at the MicroTAS meeting in San Diego, CA.
- This flat polymer film 14 preferably has a lower surface 15 and a hydrophobic upper surface 16.
- food wraps, and stretchable wax films can be used .
- the hydrophobic upper surface 16 of the film 14 is abutted by the protrusions 5 of the container 2.
- the protrusions 5 keep the flat polymer film 6 at a distance "d" to the base side 4 of the container 2.
- This distance "d” is set by the height of the protrusions 5 of the container 2, and defines at least one gap 17 when the container 2 is positioned on the flat polymer film 14.
- the gap 17 between the upper hydrophobic surface 16 of the film 14 and the base side 4 of the container is sized to accommodate a liquid drop- let.
- this gap 17 is less than 2 mm.
- the gap 17 is less than 1 mm.
- the biological sample 9 preferably is contained a well 6. It can be mixed with a liquid 18, such as a buffer solution with or without lysis reagents.
- the biological sam- pie 9 may be displaced from the at least one well 6 (while kept within a liquid droplet 19), through the channel 12 of the container 2 onto the hydrophobic upper surface 16 of the flat polymer film 14.
- the liquid droplet 19 with the biological sample 9 is thus placed in the gap 17 between the film 14 and the container 2.
- the displacement may be performed, without using valves, by a pressure applied, centrifugal force, or electrowetting against the capillary forces that prevent leaking of liquids out of the wells 6,6'.
- the biological sample processing system 1 comprises furthermore a liquid droplet manipulation instrument 20.
- This instrument 20 comprises at least one electrode array 21, a substrate 22 which supports the at least one electrode array 21 and a control unit 23.
- the liquid droplet manipulation instrument 20 is accomplished so that the container 2 and the film 14 can be reversibly attached to the instrument 20. Thereby, the lower surface 15 of the film 14 abuts the electrode array 21.
- the biological sample processing system 1 enables the displacement of a liquid droplet 19 from the at least one well 6 of the container 2 onto the upper surface 16 of the flat polymer film 14 and accordingly above the at least one electrode array 21.
- the electrode array 21 is accomplished to induce movements of the liquid droplets 19.
- the instrument 20 is accomplished to control a guided movement of said liquid droplet 19 on the upper surface 16 of the flat polymer film 14 by electrowetting and to process there the biological sample 9.
- Typical biological samples 9 which are processable by a biological sample processing system 1 are nucleic acids or proteins.
- nucleic acids are used for processing .
- Such nucleic acids comprise DNA (desoxyribonucleic acid, for example genomic DNA, cDNA, mtDNA), RNA (ribonucleic acid, for example mRNA), being single- or double stranded, and derivatives thereof (for example artificially labeled nucleic acids.
- These biological samples 9 may be contained in tissue samples such as oral mucosa cells or hair follicles.
- the biological samples 9 may be contained in a liquid, such as samples of body fluids such as blood, urine, sputum etc.
- a biological sample 9 of interest can be processed by a biological sample processing system 1 according to the present invention independent of its origin .
- samples taken for example from patients (in routine diagnostic procedures) or from a crime scene (in criminal forensics).
- the selection of required reaction reagents 10 should be adopted based on the material which comprises the biological sample 9.
- a purification step is not necessarily required during the processing within the biological sample processing system 1.
- the at least one well 6 of the container 2 is sized to accommodate a solid substrate 24 which carries the biological sample 9. This solid substrate 24 might be a tissue sample.
- this solid substrate 24 is a swab, a spatula, a needle, a syringe, a piece of paper such as FTA paper, or fabric material such as clothing, or other substrate suitable for carrying and/or collecting a biological sample 9 or e.g. tissues comprising the sample 9.
- the solid substrate 24 is a swab head, and accordingly, the at least one well 6 of the container 2 is sized to accommodate a swab head .
- An exemplary embodiment of a well 6 accommodating a swab head is shown in Figure 1.
- a typical size of such a well 6 for a swab head has a diameter of about 10 mm and a height of about 40 mm.
- a swab head may be made for example of cotton or polyester, as commonly known in the art.
- These solid samples 24 may carry as well tissue samples or biological samples 9 in form of a liquid (such as bodily fluids).
- a container 2 is shown to comprise one well 6 sized to accommodate a swab head, and further wells 6' which are different from the sample well 6 in size.
- the container 2 comprises at least one sample well 6 and six smaller wells 6' for storing reaction reagents. These wells 6' are preferably sized to store reaction reagents 10 and oth- er required liquid such as buffers.
- a typical size of such a well 6' for storing reaction reagents 10 has a diameter of about 5 mm and a height of about 40 mm.
- the size of each well 6,6' of the container 2 may be adopted individually according to the requirements given by the underlying question to be solved.
- the position of the wells 6,6' within the container 2 may be adopted as depending on the design of the liquid droplet manipulation instrument 20, production methods etc.
- the wells 6,6' are positioned in the outer regions of the container 2, to provide a central area beneath the container for moving liquid droplets 19 and for processing the sample 9 within the liquid droplet 19.
- drops of reaction reagents 10 can be transferred onto the hydrophobic upper surface 16 of the flat polymer film 14 and mixed there with a droplet 19.
- the at least one well 6 having a solid substrate 24 carrying the biological sample 9 may also comprise a reaction reagent 10.
- a reaction reagent 10 is suited to free the biological sample 9 from the material it is contained in.
- a lysis re- agent for example would be well suited for these purposes. It might comprise a reaction buffer and means to enzymatically open the cellular envelope hosting the biological sample 9.
- the reaction reagent 10 may be positioned within the well 6 in form of a liquid . Depending on the application and availability however, the reaction reagent 10 may alternatively be positioned within the well 6 for example in a ly- ophilized form. This form of reaction reagent 10 is preferred in the case when the container should be purchasable having preloaded reaction reagents 10.
- the container 2 of the biological sample processing system 1 comprises at least one well 6 which is accomplished as storage for a reaction reagent 10.
- the container 2 comprises already one well 6 for positioning a biological sample 9.
- the container comprises at least two wells 6, one well 6 for positioning the biological sample 9 and one well 6' for storing a reaction reagent.
- Stored reagents 10 comprise reagents selected from a group comprising reagents for performing cell lysis, reagents for performing nucleic acid purification, reagents for performing nucleic amplification and reagents for performing sequencing of nucleic acids.
- the cellular integrity is disrupted by opening cell membranes.
- This step can be performed using for example enzymatic activity or chemical lysis.
- other procedures to disrupt cellular integrity may be suitable.
- the thermostable protease EA1 manufactured by ZyGemTM Corporation (Waikato Inno- vation Park, Ruakura Road, Hamilton, New Zealand) should be mentioned at this place as a suitable enzyme for performing cell lysis.
- cell lysis may be carried out using Proteinase K, or chemical lysis, both procedures also well known in the art.
- the buffer matching to the used enzyme can be chosen by a skilled person without the need of special efforts and is regarded to be based on the general knowledge in the art, too. As the procedure of performing cell lysis is well known to a skilled person, it should not be described here in more detail .
- DNA purification processes are well known in the art, too, and the single procedural steps should not be explained here.
- a purification step is preferred in such cases where the sample mixture comprises elements which might distract following reactions.
- such a purification step is desired preferably after a cell lysis or after nucleic acid amplification processes such as polymerase chain reaction or sequencing by synthesis.
- DNA is to be purified.
- reagents for performing nucleic acid purification comprise beads or particles, eventually modified, which are capable to bind DNA directly or indirectly. After DNA-binding, undesired contents of the sample mixture can be washed off, and DNA can be resolved in a desired liquid .
- Such beads may be standard magnetic beads well known in the art.
- Advantageous beads include DNA IQTM offered from Promega Corporation (2800 Woods Hollow Road, Madison, WI 53711 USA) or Dy- nal® Magnetic Beads offered from Invitrogen Ltd (European Headquarters: 3 Fountain Drive, Inchinnan Business Park, Paisley PA4 9RF, UK).
- Suitable beads or particle may also be modified. Such a modification may simplify and specify the purification, as is mediates binding of specifically labeled DNA.
- DNA labeling can be achieved during an amplification process.
- a typical label used for primer in polymerase chain reaction is biotin; however, other labels suitable can be used in the context of the present invention.
- the labeled primer, incorporated into the ampli- con can be captured in the subsequent purification process using for example streptavidin coated beads.
- Dynal® Magnetic beads may be used also in this second purification step.
- PCR Polymerase chain reaction
- PCR comprises a cyclic repetition of three basic, temperature specific steps: a nucleic acid denaturation step separating the double strands of DNA at preferably 98°C, an annealing steps allowing preselected primer (oligonucleotides) to bind to respective sequences on the single strand, wherein this temperature step depends on the primer sequence, and an extension step involving a polymerase which extends bound primer to a nucleic acid strand at an enzyme specific temperature.
- the polymerase is preferably thermostable, so that it is not influenced by the denaturation temperature.
- thermostable polymerase well known in the art is the polymerase of the bacterium Thermus aquaticus (Taq-polymerase). However, other thermostable polymerases available may be used.
- Preferred templates are genomic DNA or cDNA. Using PCR, pre- selected, specific regions of a template may be amplified, giving for example more information about the origin of the DNA. Preferred regions to be analyzed by PCR comprise mitochondrial DNA (mtDNA), typical short tandem repeats (STR), or distinct single nucleotide polymorphisms (SNPs) known for being for example linked with specific diseases (used as genetic markers).
- mtDNA mitochondrial DNA
- STR typical short tandem repeats
- SNPs single nucleotide polymorphisms
- Sequencing of specifically amplified DNA is a well known tool to further characterize the selected DNA.
- Major sequencing principles are known in the art, sequencing by amplification and sequencing by hybridization. Sequencing by amplification involves a PCR-related process using however labeled stop-primer which terminate the ex- tension process randomly. The resulting end-labeled fragments are then used for determining the sequence of the template.
- Sequencing by hybridization involves the linkage of labeled primer to a matrix. Primer are selected so that the overlap partially in their sequence. After hybridization of a target DNA to said pri- mer, sequence can be determined by the analysis of primer sequenced to which the target is bound .
- the labeled primers are preferably linked to the hydrophobic upper surface 16 of the flat polymer film 14 prior to the start of sample processing . Most preferably, the labeled primers are linked prior to the release of the system into the trade.
- the container 2 comprises more than two wells 6,6'.
- the container 2 comprises at least one well 6 for positioning a biological sample 9 and further wells 6' for storing the required reaction reagents 10, with one dedicated well 6' for each reaction reagent 10 of one method .
- the well 6 for positioning the biological sample 9 is accomplished to store additionally reaction reagents 10 and buffers required for cell lysis. Cell lysis can thus be per- formed directly in the well 6 which holds the biological sample 9.
- the container 2 then comprises at least four wells 6,6': one well 6 for positioning the biological sample 9 and storing reaction reactions 10 for cell lysis, one well 6' for storing reaction reagents 10 for DNA purification, one well 6' for storing reaction reagents for PCR, and one well 6' for storing reaction reagents 10 for sequencing .
- the container 2 comprises at least ten wells 6,6' for processing of a biological sample 9 :
- At least one well 6 is accomplished for positioning the biological sample 9, for storing reaction reagents 10 and buffer and for performing cell lysis, at least three wells 6' are accomplished for pre-PCR purification (one each for magnetic beads, wash buffer, and elute buffer),
- At least two wells 6' are accomplished for amplification (one for storing the enzyme and buffer, one for storing the primer, with one primer well per locus to be amplified),
- At least two wells 6' are accomplished for post-PCR clean-up (one for storing streptavidin coated beads and one for storing wash buffer),
- At least two wells 6' are accomplished for storing reaction reagents 10 and buff- er for sequencing by hybridization (one for storing buffer comprising a reference probe and one for storing buffer comprising a probe of interest).
- the number of wells 6,6' is dependent on the type of reaction system used (required reagents, processing steps) and the number of analysis required (number of sequences/loci to be analyzed, i.e. STR, SNP, mtDNA) and may be adopted by a skilled person based on general knowledge in the art.
- the primer for the amplification should be stored in the container 2, preferably the container 2 comprises one primer well per loci to be analyzed for the amplification process.
- the container preferably comprises 16 primer wells 6' for the amplification.
- the primer required for the amplification step may be available in dried form on the hydrophobic upper surface 16 of the flat polymer film 14, so that for storing primer, no separate well 6' would be required here in the container 2.
- the primer may in this case be re-suspended on the film 14 using a buffer held in a well 6'.
- the number of wells 6' required storing reaction reagents 10 and buffer may similarly be adopted.
- the biological sample processing system 1 is accomplished to perform the extraction, purification, amplification and analysis of a biological sample 9 of interest.
- the present invention provides according to the first aspect a fully integrated system that can directly accept macro-volumes of sample (either in liquid form or on a solid surface such as a buccal swab) and process utilizing nano-volumes up to the final analysis.
- a container 2 according to the present invention is shown in a top view, having one well 6 for positioning the biological sample 9 and six further wells 6' for storing reaction reagents 10.
- the biological sample 9 When cell lysis is performed directly within the well 6 for positioning the biological sample 9, the biological sample 9 is set free from the cellular context, and preferably released into a liquid 18, which therefore is a reaction solution resulting from the cell lysis.
- the liquid can be chosen according to the following procedural steps, and added into the well via the top side 7 of the well 6.
- the biological sample 9 should be contained at least in parts in a liquid for the further processing using the biological sample processing system 1 according to the first aspect of the present invention.
- the liquid 18 or a liquid droplet containing at least parts of the biological sample 9 is then displaced for further processing from the well 6 through the channel 12 of the container 2 onto the hydrophobic upper surface 16 of the flat polymer film 14.
- the displacement preferably performed, without using valves or other moveable means, by a pressure applied, by centrifugal force, or by electrowetting . All these preferred displacement means act against the capillary forces that prevent leaking of liquids out of the wells 6,6'. However, also other means may be used which are suitable to displace the liquid 18 or liquid droplet 19 from the well 6 onto the hydrophobic upper surface 16 of the flat film 14.
- the container 2 and the flat polymer film 14 are reversibly attached to the liquid droplet manipulation instrument 20, with the lower surface 15 of the film 14 abutting the electrode array 21. Accordingly, the liquid droplet 19 is displaced from the well 6 above the electrode array 21.
- the liquid droplet 19 may be moved in a guided manner by the liquid manipulation instrument 20 by electrowetting. The movement is controlled to achieve the selected processing of the biological sample 9 contained within said liquid droplet 19 and to carry out this processing at preferred sites of the electrode array.
- the liquid droplet 19 is moved in the gap 17 within an immiscible system liquid 32. This variant is the preferred embodiment, when performing PCR on the biological sample 9 contained in the at least one liquid droplet 19.
- PCR requires the exposure of such a liquid droplet 19 to different temperatures, including the denaturation step at about 98°C, evaporation of liquid may be prevented or at least considerably reduced with the use of such an immiscible system liquid 32.
- Preferred system liquids immiscible with the liquid droplet 19 are selected e.g . from silicon oil, hexadecane and benzene.
- container 2 and instrument 20 preferably comprise each at least one positioning element 25.
- positioning elements are preferably selected from a group comprising : at least one groove in the lateral area 28 of the container 2 and at least one elevation extending from the instrument 20 in such a way that when the container 2 with the film 14 is attached to the instrument 20, groove and elevation are arranged form-fitting to each other;
- the container 2 having an irregular polyhedron shape and the liquid manipulation instrument having a corresponding groove, so that when attaching the container 2 to the instrument 20, both are aligned in a form-fitted snugly manner.
- Positioning elements 25 accomplished as at least one groove of the container 2 and at least one elevation extending from the instrument 20 are presented in Figure 1 (with the groove at the base side 4 of the container 2), Figure 2A (with two triangular-shaped grooves in the lateral area of the container) and in Figure 2B (with two semi-circular shaped grooves in the lateral area of the container 2).
- a Peltier element for heating the well 6 for positioning the biological sample 9 such Peltier element can be accomplished as an elevation extending from the instrument 20, its position may be chosen so that for example, is specifically provides the well 6 (whether this is central or not) with a defined temperature.
- other means for positioning the container 2 on the liquid droplet manipulation instrument 20 in a defined configuration may as well be used which are well known to a skilled person, and should not be described in more detail here.
- a liquid droplet 19 on the flat polymer film 14 may either contact only the hy- drophobic upper surface 16 of the film 14 or may contact both, the hydrophobic upper surface 16 of the film 14 and the base side 4 of the container 2.
- the contact surfaces of such a liquid droplet 19 may be influenced by the sizing of the gap 17 (thus, sizing the protrusions 5) or by sizing the liquid droplet 19.
- the container 2 is preferably made by injection molding. In this way, the production costs may be reduced despite the achievable high manufacturing quality and the container 2 can be utilized as a low cost disposable.
- Such a single-serving container 2 is suited to be sold for various applications and can be equipped with a specific set of reaction reagents 10.
- the container 2 is preferably made either of an electri- cally insulating material 26, of an electrically conductive material 27, or of a combination of both an electrically conductive and an electrically insulating material 26,27.
- a two step injection process is preferred .
- the core of the container 2 is made of an electrically insulating material 26, wherein the regions surrounding the wells 6,6' are made from an electrically conductive material 27.
- the surrounding regions made of the conductive material 27 are separated from each other by the insulating material 26.
- These surrounding regions made of conductive material 27 may form at the base side 4 of the container 2 a nozzle 47, which slightly extends into the gap 17 (see Figure 1).
- the advantage provided by such a nozzle is the possibility to dis- tinctly produce and deliver a liquid droplet 19 into the gap without the droplet 19 contacting the surface of the base side 4 of the container 2. Furthermore such a nozzle may enable a directed delivery of the droplet 19 into the gap 17.
- parts of the surrounding regions made from the electrically conductive material 27 form a part of the outer, lateral side 28 of the container 2.
- Such a variant has the advantage, that each electrically conductive region 27 of the container 2 may be individually contacted electrically.
- the at least one well 6 for positioning a biological sample 9 is arranged towards the outer, lateral side 28 of the container 2.
- the at least one well 6 is additionally surrounded from an electrically conductive material 27.
- the electri- cally conductive surrounding 27 is in this variant extends to form the major part of the core of the container 2.
- major parts of the base side 4 of the container 2 are made of electrically conductive material 27, too.
- This allows processing a liquid droplet 19, which is positioned on the hydrophobic upper surface 16 of the film 14 and which contacts the base side 4 of the container 2, by electrowetting us- ing the electrically conductive parts of the base side 4 of the container 2 as a ground electrode. Accordingly, in this variant, the guided movement of the liquid droplet 19 may be further stabilized .
- the container 2 When the container 2 itself is subjected to a heating step, for example to promote cell lysis within the at least one well 6 for positioning the biological sample and/or a reaction reagent, it is preferred that part of the container 2 is made from a thermally isolating material or that thermally insulating gaps are provided around the zone of higher temperature.
- the container 2 comprises means for identification 30, which are selected from a group comprising a barcode and an RFID (radio- frequency identification) tag or another integrated chip. As such means for identification 30 are well known to the person skilled in the art, they should not be described in more detail here.
- Identification means 30 are especially preferred when the container 2 of the biological sample processing system 1 is used in an automated manner, while storing information for example about the biological sample positioned in a well 6 of the container 2. In addition, tracking of a particular sample is possible even in a large laboratory system.
- this well 6 preferably comprises retention means 31 for preventing the solid substrate 24 to block the opening 8 of said well 6.
- the retention means 31 are selected from a group comprising a filter, a frit (see Fig . 1) and relief structures (see Fig. 2B). However, other retention means 31 well known in the art may be used for these purposes.
- FIGS. 2A and 2B each show a container 2 having an analyzing area 33.
- a container 2 having an analyzing area 33 is preferred, when certain areas of the hy- drophobic upper surface 16 of the flat polymer film 14 should be accessible by optical means 38.
- a cut-out section defines the analyzing area 33, preferably in the outer lateral side 28 of the container 2.
- the respective region of the hydrophobic upper surface 16 of the film 14, underlying the cut-out is in this way accessible for optical means 38.
- Such optical means are e.g. a human eye or an optical device.
- Figures 2A and 2B show exemplarily a preferred position of an optical means in relation to the analyzing area 33.
- the analyzing area 33 is positioned above that region of the hydrophobic upper surface 16, which is accomplished to the processing of a biological sample 9 using sequencing, especially preferred when as the sequencing method sequencing by hybridization method is performed.
- optical devices 38 are selected from a group comprising a standard microscope, a camera system, a light guiding system such as fiber optics, a scanner, and adaptations or combinations thereof.
- a camera, a simple CCD or a PMT (Photo Multiplier Tube) is used together with a light source, such as an LED, which serves as an excitation source for fluorescent tags on the film 14.
- a light guiding system is used, the excitation- and/or measurement device may be located aside of the container 2.
- the container 2 preferably comprises a support rim 45 when having an analyzing area 33.
- This support rim 45 extends along the outer lateral side 28 of the container 2 while bordering the analyzing area 33. Accordingly, this support rim 45 may also comprise one or more protrusions 5 at its bottom side, which are attached to the hydrophobic upper surface 16 of the flat polymer film 14.
- This support rim 45 supports the container 2 having a cut-out when positioned on the film 14.
- a multitude of containers 2 having at least one analyzing area 33 is arranged in such a way, that each analyzing area 33 is easily accessible by one optical device 38.
- One possible way would be an essentially circular arrangement of the containers 2 around a rotary optical device 38.
- the containers 2 can be stored in vertical or horizontal rows of adequate carrier, and the optical device 38 or the carrier with the row of container 2 are shifted manually or automatically into a position in which the analyzing 33 is accessible by the optical device 33.
- Both, the container 2 and the flat polymer film 14 can be provided to the user either as separate components that remain to be assembled when the processing of a biological sample 9 is to be started.
- these two components can be provided as a cartridge 40.
- the cartridge comprises both, container 2 and the flat polymer film 14, which are attached to one another for example by gluing or welding or other appropriate means to stably attach these two components.
- the container 2 or the cartridge 40 comprises a cover 43 for protecting the wells 6,6' and their content from outside influences.
- a cover 43 may be sealingly attached to the top side 7 of the container 2. The attachment may be reversible.
- the cover 43 is a thin film, which optionally is made of a pierceable material . In this way, the wells 6,6' of the container 2 may be preloaded. Safe storage is allowed by applying the film cover 43 onto the container 2. Only upon start of the sample processing, the film cover 43 is pierced open and the wells 6,6' of the container 2 are accessible for the user. Additionally, the container 2 or the cartridge 40 can be covered with a cover 43 as well.
- the present invention relates to a liquid droplet manipulation instrument 20.
- this liquid droplet manipulation instrument 20 is accomplished to be used in the biological sample processing system 1 according to the first aspect of the present invention.
- the liquid droplet manipulation instrument 20 may be used independently of the biological sample processing system 1.
- the liquid droplet manipulation instrument 20 comprises at least one array of electrodes 21 for inducing a movement of a liquid droplet by electrowetting .
- the liquid droplet manipulation instrument 20 also comprises a substrate 22 for supporting the electrode array 21, and a control unit 23.
- the control unit 23 comprises at least one electrode selector 34, which is connected with at least one voltage control 29.
- the electrode selector 34 is accomplished to individually select each electrode 35 of the electrode array 21.
- the electrode selector 34 is accomplished to provide the selected electrode 35 with a voltage which is controlled by the voltage control 29.
- At least the electrode selector 34 and the voltage control 29 are controlled by a central processing unit 36, which is comprised by the control unit 23.
- the central processing unit 36 is accomplished to control the electrode selector 34 and the voltage control 29 to individually select at least one electrode 35 and to provide the selected electrode 35 with an individual voltage pulse.
- the individual voltage pulse is selected from a group comprising a ground voltage and a drive voltage.
- the selected electrode 35 is defined as a drive electrode 35' or as a ground electrode 35".
- the electrodes 35 of the electrode array 21 may have various shapes. Generally, those shapes of electrodes 35 are preferred which are suitable to establish an array of these electrodes 35.
- the Figures 3A - 3D show some examples of preferred electrode-shapes. As can be seen in Figure 3A, the electrodes 35 may have a rectangu- lar shape. Here, the electrodes 35 have a square shape; however, other rectangular shapes may as well be suitable. In Figure 3B, the electrodes 35 are shown as having a hexagonal shape, in Figure 3C as having a circular shape and in Figure 3D as having a triangular shape. However, other shapes may be suitable as well, as long as the electrodes 35 are able to establish an array and are accessible by electrode contacting lines.
- the central processing unit 36 comprises activatable software 37.
- This software 27 enables the central processing unit 36 to control the electrode selector 34 and the voltage control 29 to individually select at least one electrode 35 and to provide the selected electrode 35 with an individual voltage pulse.
- the control unit 23 preferably comprises a power supply 44.
- This power supply 44 provides at least the central processing unit 36 and the voltage control 29 with electric power.
- the power supply 44 may additionally provide also other elements with electric power.
- the control unit 23 is capable to define a path for a guided movement of a liquid droplet 19 by the selection of a series of subsequent drive electrodes 35'. Thereby at least one of these selected drive electrodes 35' is subsequently provided with a drive voltage pulse along said path, under the control of the control unit 23. Furthermore the control unit 23 is accomplished to essentially simultaneously provide at least one electrode 35", which is adjacent to the pulsed drive electrode 35' and different to the selected drive electrode 35' of the path, with a ground voltage pulse.
- Such a path for a guided movement of the liquid droplet is each shown in the Figures 3A to 3D.
- the subsequent selected drive electrodes 35' are indicated .
- the ac- tual drive electrode 35' is shown to be that electrode 35, upon which the liquid droplet 19 is positioned.
- the direction of the planned guided movement of the liquid droplet 19 is indicated with an arrow. In that direction, subsequent electrodes 35' along the path will be provided with a drive voltage pulse.
- the size, respectively the diameter of the liquid droplet 19 slightly exceeds the diameter of an electrode 35.
- the liquid droplet touches not only the actual drive electrode 35' but slightly touches simultaneously the subsequent electrode 35' which will become the next actual drive electrode 35'.
- the presence of at least one ground electrode 35" adjacent to the liquid droplet 19 to be moved provides a stabilizing effect to its movement.
- the Figures 3A-3D indicate those electrodes 35" that might be provided with a ground voltage pulse. Those ground electrodes 35" are preferably adjacent to the pulsed drive electrodes 35' and different or identical to the selected drive electrodes 35' of the path.
- the provision with the ground voltage pulse is preferably carried out essentially simultaneously to the provision with the drive voltage pulse. Alternatively, the provision with the ground voltage pulse is to be carried out simultaneously to the provision with the drive voltage pulse.
- the control unit 20 is accomplished to provide at least two electrodes 35" which are adjacent to the pulsed drive electrode 35' and different to the selected drive electrode 35' of the path with a ground voltage pulse.
- these at least two se- lected ground electrodes 35" are subsequent electrodes 35 on the same side of the path.
- ground electrodes 35" may be selected from electrodes 35 along the path, adjacent to the path and adjacent to the liquid droplet 19.
- the selected ground electrodes 35" are on the same side of the path.
- at least two first electrodes 35" are preferably selected from one side of the path.
- the remaining electrodes 35" of that group may however be selected from that side of the path being opposite to the first two ground electrodes 35" of that group.
- a group of ground electrodes 35" are selected from two sides of the path, they are provided with the ground voltage pulse essentially simultaneously or simultaneously to the pulsed drive electrode 35'.
- the other electrodes 35" may be adjacent to the path and ahead of the liquid droplet 19, adjacent to the path and behind the liquid droplet 19 or both.
- a group of 2 or more electrodes 35 may be provided with a drive voltage pulse essentially simultaneously. In this case, a liquid droplet 19' of a larger volume may be moved. However in this variant it is preferred that essentially simultaneously or simultaneously a group of 2 or more electrodes 35 are provided with a ground voltage pulse to sufficiently support the liquid droplet 19' with the larger volume.
- control unit is accomplished to provide at least one selected electrode with a stop voltage pulse for generating a stop electrode 35"'.
- the provided stop voltage pulse is different to the drive voltage pulse and the ground voltage pulse.
- the voltage pulses for defining a selected electrode 35 as a drive electrode preferably are between 20 and 100 V.
- the voltage pulses for defining a selected electrode 35 as a stop electrode preferably are between -50 V and +50 V.
- selected stop electrodes 35"' are adjacent to the path, different to the selected drive electrode 35' of the path and different to the at least one selected ground electrode 35" adjacent to the path.
- stop electrodes 35"' are selected from such electrodes 35 adjacent to the path, where the path provides a change of direction for the liquid droplet 19 movement.
- a stop electrode 35"' supports the direction change of the liquid droplet movement along the path.
- FIGS 3A-3D show exemplarily possible positions of stop electrodes 35"' along the path.
- at least one electrode 35"' along the path at a place of direction change is provided with a stop voltage pulse.
- more than one electrode 35"' in that area may be selected to be provided with a stop voltage pulse, as shown in Figure 3D.
- two ore more electrodes are selected as stop electrode 35"' at the point of direction change to support the liquid droplet movement.
- FIGS. 3B and 3C show exemplary a virtual grid of the electrode array 21.
- Each grid point 39 of the virtual grid is established by the geometrical centre of each electrode 35 of the electrode array 21.
- Figure 3B shows a hexagonal grid according to the hexagonal shape and dense packing of each electrode 35 of the electrode array 21.
- Figure 3C shows an orthogonal grid based on the orthogonal arrangement of electrode 35, this time exhibiting essentially circular shape.
- subsequent electrodes for defining the path, subsequent selected ground electrodes 35", and/or subsequent selected stop electrodes 35"' are defined by the closest distance between two grid points 39 of that virtual grid . In this way a continuous liquid droplet movement may be ensured.
- the hexagonal arrangement of the electrodes array 21 is preferred over the orthogonal arrangement because of the higher degree of freedom.
- Figure 1 shows exemplarily the position of the electrodes 35 in relation to the substrate 22.
- the electrodes 35 of the electrode array 21 are positioned in relation to the substrate 22, so that the upper surface of the electrodes 35 are aligned substantially flush with the upper surface of the substrate 22.
- the electrodes 35 of the electrode array are positioned within the substrate 22 and enclosed by it (see left hand side on Fig . 1) . It is preferred to position the electrodes 35 as close to the liquid droplets 19 as possible in order to be able to reduce the voltage necessary for electrowetting.
- electrodes 35 flush with the upper surface of the substrate 22 and very thin polymer films are particularly preferred .
- As a material for the thin polymer films e.g . food wraps, and stretchable wax films can be used .
- the liquid droplet manipulation instrument 20 is accomplished to accommodate a container 2 for large volume processing and to simultaneously accommodate a flat polymer film 14 with a hydrophobic upper surface 16.
- a system is formed suited for bio- logical sample processing of a sample 9 positioned within the container 2.
- Such a system preferably corresponds to the biological sample processing system 1 according to the first aspect of the present invention.
- the liquid droplet manipulation instrument 20 according to the present invention is accomplished to accommodate a cartridge 40. Said cartridge comprises a container 2 and a flat polymer film 14 as previously described herein.
- Container 2 and film 14 of the cartridge 40 are attached to one another by gluing or welding, or by other appropriate means to stably connect the container 2 and the film 14.
- a biological sample processing system 1 according to the first aspect of the present invention may be formed.
- the liquid droplet manipulation instrument 20 comprises at least two ore more electrode arrays 21.
- the electrode arrays 21 are arranged essentially horizontal within the liquid droplet manipulation system 20.
- the instrument 20 is accomplished to accommodate at least two or more containers 2 together with two or more flat polymer films 14, or to accommodate at least two or more cartridges 40.
- the container 2 and the film 14 or the cartridge 40 may be positioned essentially above the electrode array.
- the biological sample processing system 1 comprises a liquid droplet manipulation instrument 20 according to the second aspect of the present invention and as discussed in detail above.
- the embodiment of the liquid droplet manipulation instrument 20 as well as the embodiment of the biological sample processing system 1 may be chosen by selecting the various features discussed above, depending on the question addressed. If not stated otherwise, the various features presented within this application may all be combined with each other.
- a biological sample processing system 1 comprising a liquid droplet manipulation instrument 20 is shown.
- the liquid droplet manipulation instrument 20 comprises a reception element 46 to safely receive the container 2 and the film 14.
- FIG. 3A shows an electrode array 21 according to such an especially preferred embodiment of a biological sample processing system 1.
- This Figure shows an enlarged top view of a distinct section of Figure 1, indicated as a rectangle with a dotted line.
- the position of the at least one well 6 for positioning a biological sample 9 in relation to the defined path on the electrode array 21 is indicated by a dotted circular line in Figure 3A.
- the opening 11 at the bottom of the at least one well 6, the passage of the channel 12 or the orifice 13 at the base side 4 of the container 2 respectively are indicated as an inner circle of a dotted line.
- a liquid 18 or a liquid droplet 19 is transferred from the well 6 through the channel 12 on the hydrophobic upper surface 16 of the flat polymer film 14, namely above the electrode array 21 of the liquid droplet manipulation instrument 20.
- a liquid portion 19' is indicated in the center of the electrode array 21 shown. This liquid portion 19' covers at least one selected drive electrode 35' from the electrode path. Preferably, the liquid portion covers at least partially subsequent electrodes 35' from the path. According to Figure 3A, the liquid portion 19' covers additionally electrodes 35" selected to be provided with a ground voltage pulse.
- a liquid droplet 19 is separated from the liquid portion 19' by the provision of a drive voltage pulse to an electrode 35' subsequent to the initial drive electrode 35' along the path.
- the liquid droplet 19 is then guided on along the path in a first direction, and after a direction change, in a sec- ond direction. At the position of the direction change, a stop electrode 35"' is generated to stabilize the direction change.
- the liquid droplet manipulation instrument 20 of the biological sample processing system 1 comprises preferably at least one magnet 41. This magnet 41 controls the magnetic beads during the processing in the gap 17 on the upper hydrophobic side 16 of the flat polymer film 14. Suitable magnets may be electromagnets or permanent magnets.
- the magnet 41 is arranged preferably on that side of the substrate 22 of the instrument, which is not covered by an electrode array 21.
- the magnet 41 is alternatively arranged preferably on that side of the substrate 22 of the instrument 20, which is not abutted by the flat polymer film 14.
- the liquid droplet manipu- lation instrument 20 of the biological sample processing system 1 preferably comprises at least one heating element 42.
- This heating element 42 is preferably arranged on that side of the substrate 22 of the instrument 20, which is opposite to the side of the substrate 22 being abutted with the flat polymer film 14.
- the at least one heating element 42 is accomplished to provide at least one temperature zone with a predefined temperature on the upper hydrophobic surface 16 of the flat polymer film 14. If the liquid droplet manipulation device 20 comprises one heating element 42, PCR may be performed by keeping the liquid droplet 19 comprising a biological sample 9 within the single temperature zone, while changing the temperature within that single zone accordingly.
- a PCR may be done by moving the liquid droplet 19 comprising a biological sample 9 between the two zones, wherein the temperature of each zone is adopted according to the temperature required for the cycling steps.
- the biological sample processing system 1 comprises in an especially preferred variant at least three heating elements 42 for providing at least three different temperature zones on the upper hydrophobic surface 16 of the flat polymer film 14.
- Figure 1 shows a biological sample processing system 1 having three heating elements 42 underneath the support substrate 22 and opposite to the side being abutted with the flat polymer film 14.
- Each temperature zone has a predefined temperature to enable a PCR being performed on the upper hydrophobic surface 16 of the flat polymer film 14.
- one temperature zone comprises a temperature for denaturizing double stranded nucleic acid
- one temperature zone comprises a temperature enabling the annealing of pre-selected primer
- one temperature zone comprises a temperature enabling a polymerase to elongate the annealed primer to the full strand.
- the biological sample processing system 1 may comprise a fourth heating element 42 providing a temperature of about 4°C. Utilizing at least three heating elements 42 underneath the support substrate 22 has the advantage that the selected temperatures can be kept constantly over the entire reaction time and the droplets can be moved from one temperature region to another. This movement allows for rapid temperature changes within the droplets 19, which are much faster than achievable by changing the temperature of the heater element 42 while keeping the droplet 19 in place.
- a layer of low vapor pressure liquid connects the lower surface 15 of the flat polymer film 14 with the upper surface of the at least one electrode array 21 to reduce the formation of air bubbles in-between.
- the low vapor pressure liquid is silicon oil;
- FIG. 4 shows top views of a grid-like electrode array 21 according to a first preferred embodiment and similar to the array of Fig . 3A with rectangular electrodes 35.
- a particularly preferred liquid droplet manipulation instrument 20 is shown, the liquid droplet manipulation instrument 20 comprising :
- a control unit 23 comprising at least one electrode selector 34 connected with at least one voltage control 29, the at least one electrode selector 34 being accomplished to individually select each electrode 35 of the at least one electrode array 21 and to provide the selected electrode 35 with a voltage controlled by the voltage control 29; the control unit 23 further comprising a cen- tral processing unit 36 for controlling the electrode selector 34 and the voltage control 29 to individually select at least one electrode 35 and to provide the at least one selected electrode 35 with an individual voltage pulse which is selected from a group comprising a drive voltage, a ground voltage, and a stop voltage, thus defining the selected electrode 35 as a drive electrode 35', a ground electrode 35", or a stop electrode 35"'.
- control unit 23 of the liquid droplet manipulation instrument 20 is capable to define a path for a guided movement of at least one of a liquid droplet 19 and a liquid portion 19' of a larger volume that covers more than one electrode 35' of one electrode array 21 by the essentially simultaneous selection of a group of two or more subsequent drive electrodes 35' of said elec- trode array 21, and to provide each one of these selected drive electrodes 35' with a drive voltage pulse along said path;
- (e) is accomplished to essentially simultaneously provide a group of two or more electrodes 35 adjacent to or identical with the pulsed drive electrodes 35' with a ground or stop voltage pulse.
- Fig . 4A shows a liquid portion 19' of a larger volume that covers about 18 pulsed drive electrodes 35' of the same electrode array 21.
- these 18 electrodes 35 have been activated for collecting this liquid portion 19' of a larger volume, the activated electrodes 35' attracting the liquid or at least keeping it in a stable vol- ume.
- this liquid portion 19' of a larger volume is kept on the hydrophobic upper surface 16 of a flat polymer film 14 and within a gap 17, the flat polymer film 14 being exposed to the substrate 22 with the at least one electrode array 21 (compare with Fig . 1).
- Electrodes 35 Situated around the activated electrodes 35' (shown in grey), more electrodes 35 are defined as ground electrodes 35" or stop electrodes 35"' (shown in white). All electrodes 35 are operatively connected to the electrode selector 34 of the control unit 23 (only partially shown in Fig . 4A and present but not shown in the Figs. 4B and 4D).
- Fig . 4B shows a group of two electrodes 35" that are identical with previously pulsed drive electrodes 35' that now are provided with a ground voltage pulse. This causes the liquid portion 19' of a larger volume to draw back to the activated electrodes 35' and induces a partial separation (see double arrow) of the liquid portion 19' of a larger volume into two smaller portions 19' that still cover at least two pulsed drive electrodes 35' of the same electrode array 21.
- Fig . 4C shows a group of three electrodes 35" that are identical with previously pulsed drive electrodes 35' and that now are provided with a ground or stop voltage pulse (the latter even enhancing the separation effect). This causes the liquid portion 19' of a larger volume to now completely separate (see one-sided arrows to the left and right) into two smaller portions 19' that still cover at least two pulsed drive electrodes 35' of the same electrode array 21.
- separation of a small volume i.e. a single liquid droplet 19 can also be performed when using the same particularly preferred liquid droplet manipulation instrument 20 (see Fig. 5).
- Figure 5 shows top views of a grid-like electrode array according to a second pre- ferred embodiment and similar to the array of Fig . 3A with rectangular electrodes.
- a liquid portion 19' of a larger volume covers about 6 pulsed drive electrodes 35' of the same electrode array 21.
- an additional drive electrode 35' of the same electrode array 21 is activated so that the liquid portion 19' now covers about 7 drive electrodes 35' (see Fig. 5B, on-sided arrow to the right). Then, opposite to the direction, where the additional drive electrode 35' was activated in Fig. 5B, another drive electrode 35' is activated and a group of two electrodes 35" identical with previ- ously pulsed drive electrodes 35' are provided with a ground or stop voltage pulse. This causes a liquid droplet 19 to be dispensed and the remaining liquid portion 19' of a larger volume to move in different directions (see double arrow in Fig . 5C). Providing the group of two electrodes 35" with a stop pulse even enhances the desired separation effect.
- a combination of using a drive path of three rows of electrodes 35 (as e.g . shown in Fig . 4) and an electrode path of a single electrode row that closely reaches to the electrode array 21 (compare with Fig . 3A) is preferably used for dispensing small liquid volumes, i.e. single liquid droplets 19 when utilizing the same particularly preferred liquid droplet manipulation instrument 20 (see Fig . 6).
- Figure 6 shows top views of a grid-like electrode array 21 according to a third preferred embodiment and similar to the array of Fig . 3A with rectangular electrodes 35 and an electrode path adjacent to the electrode array 21.
- a liquid portion 19' of a larger volume covers about 10 activated electrodes 35' of the electrode array 21. All electrodes 35 of the electrode path are inactive (e.g . on a ground or on a stop potential). Preferably these 12 electrodes 35 have been activated for collecting this liquid portion 19' of a larger volume, the activated electrodes 35' attracting the liquid or at least keeping it in a stable volume. Most preferably, this liquid portion 19' of a larger volume is kept on the hydrophobic upper surface 16 of a flat polymer film 14 and within a gap 17, the flat polymer film 14 being exposed to the substrate 22 with the at least one electrode array 21 (compare with Fig . 1).
- All electrodes 35 are operatively connected to the electrode selector 34 of the control unit 23 (only partially shown in Fig. 6A and present but not shown in the Figs. 6B to 6F).
- the first two adjacent drive electrodes 35' of the electrode path are activated and the previously activated 12 electrodes 35 of the array 21 are inactivated (see Fig . 6B).
- Inactivation in this case means providing the 12 electrodes 35 of the electrode array 21 with a ground voltage pulse.
- This combined action of the first two adjacent drive electrodes 35' of the electrode path and the 12 electrodes 35 of the array 21 causes the liquid portion 19' of a larger volume to move to the left and spread over the first two adjacent drive electrodes 35' of the electrode path (see one-sided arrow to the left).
- the third drive electrode 35' of the electrode path is activated, the first two adjacent drive electrodes 35" are inactivated and a group of 9 electrodes 35' of the electrode array are activated as well.
- three electrodes 35" of the electrode array are inactivated .
- Inactivation in this case means providing the first two adjacent drive electrodes 35" of the path with a ground or with a stop pulse. This causes separation (or dispense) of a first liquid droplet 19 from the liquid portion 19' of a larger volume by moving the liquid droplet 19 to the third electrode 35 of the path and by moving back the residual liquid portion 19' to the activated electrodes 35' of the electrode array 21 (see one-sided arrows to the right and left). Providing the two adjacent drive electrodes 35" with a stop pulse even enhances the desired separation effect. The remaining liquid portion 19' now covers about 9 electrodes of the electrode array.
- the fourth drive electrode 35' of the electrode path is activated, the second and third drive electrodes 35" are inactivated.
- Inactivation in this case means providing the second and third drive electrodes 35" of the path with a ground or with a stop pulse. This causes moving of the first liquid droplet 19 to the fourth electrode 35' of the path (see one-sided arrow to the left) .
- the first drive electrode 35' of the electrode path is activated together with adjacent 9 electrodes 35' of the electrode array 21 and three electrodes 35" of the electrode array are kept inactivated . This causes the liquid portion 19' of a larger volume to move to the left and spread over the first adjacent drive electrode 35' of the electrode path (see one-sided arrow to the left). Inactivation with respect to the three electrodes 35" of the electrode array 21 forces a concentration of the residual liquid portion 19' of a larger volume to the electrodes 35' in vicinity to the electrode path.
- the fifth drive electrode of the electrode path is activated and the fourth drive electrode is inactivated .
- This causes moving of the first liquid droplet 19 to the fifth electrode 35' of the path (see one-sided arrow to the left).
- the first three drive electrodes 35' of the electrode path are activated and all electrodes of the electrode array are inactivated .
- This causes the liquid portion 19' of a larger volume to move to the left and spread over the first three drive electrode 35' of the electrode path (see one-sided arrow to the left).
- the fifth and third drive electrodes 35' of the electrode path stay activated while the fourth and the first two drive electrodes are inactivated .
- This causes keeping the first liquid droplet 19 on the fifth electrode 35' and separation of a second liquid droplet 19 on the third electrode 35' of the path (see one-sided arrows to the left).
- 6 electrodes 35 of the array 21 are activated, which causes the remaining liquid portion 19' withdrawing to the electrode array 21, from which it now covers about 8 electrodes (see one-sided arrow to the right).
- the already separated liquid droplets 19 have at least to be moved to the next drive electrode 35' in each case and a similar situation is created as depicted in Fig . 6D.
- a dielectric layer is provided on the surface of the electrode array 21.
- the dielectric layer is part of the substrate 22 of the liquid droplet manipulation instrument 20 or part of the flat polymer film 14.
- the gap preferably 17 is closed on its upper side by a dielectric layer with a hydrophobic surface, so that the liquid droplets 19 or the liquid portions 19' are moved and manipulated in the gap 17 between two hydrophobic surfaces.
- the gap 17 may be partially or totally filled with a fluid that is not miscible with the liquid droplets 19 or the liquid portions 19', the fluid preferably being selected from air, a chemically inert gas (like e.g.
- the substrate 22 may be selected from materials like a printed circuit board (PCB), a polymer, glass, or compound materials.
- PCB printed circuit board
- all electrodes 35 are arranged in the same plane; however arranging the electrodes 35 in different planes or in planes of different inclination is envisaged too.
- manipulating liquid droplets 19 or liquid portions 19' "dispensing" liquid droplets 19 from larger portions 19', "splitting” liquid droplets 19 into smaller droplets, and “separating" larger portions 19' into several parts is termed manipulating liquid droplets 19 or liquid portions 19', whether the larger liquid portions 19' need “pumping” or not.
- manipulating liquid droplets 19 or liquid portions 19' "joining" small liquid droplets 19 with each other (e.g . for mixing reaction partners) or with larger liquid portions 19', and "as- sembling" larger liquid portions 19' is also termed manipulating liquid droplets 19 or liquid portions 19'.
- the controlled reduction of the size of an electrode array 21 with the goal of forcing a larger liquid portion 19' in a desired direction, e.g . to the site where an electrode part is joining the electrode array 21, is termed "pumping".
- a number or "grid” of equally sized electrodes 35 may be termed a “reservoir” or a “manipulation array”. Any combination of features of the different embodiments of electrode arrays disclosed in this patent application that lays within the borders of the appended claims and that appears reasonable to a person of skill is comprised by the gist and scope of the present invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/784,168 US8936708B2 (en) | 2008-12-17 | 2013-03-04 | Manipulating the size of liquid droplets in digital microfluidics |
PCT/EP2013/069703 WO2014135232A1 (en) | 2013-03-04 | 2013-09-23 | Manipulating the size of liquid droplets in digital microfluidics |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2931425A1 true EP2931425A1 (de) | 2015-10-21 |
EP2931425B1 EP2931425B1 (de) | 2021-03-24 |
Family
ID=49263298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13770655.2A Active EP2931425B1 (de) | 2013-03-04 | 2013-09-23 | Handhabung der grösse von flüssigkeitstropfen in digitalen mikrofluiden |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2931425B1 (de) |
CN (1) | CN105008052B (de) |
WO (1) | WO2014135232A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2542372A (en) * | 2015-09-16 | 2017-03-22 | Sharp Kk | Microfluidic device and a method of loading fluid therein |
EP3368668B1 (de) * | 2015-10-28 | 2023-11-29 | Silicon Valley Scientific, Inc. | Verfahren und vorrichtung zur codierung von zellularen räumlichen positionsinformationen |
WO2017173530A1 (en) | 2016-04-08 | 2017-10-12 | The Governing Council Of The University Of Toronto | Surfactant additives for digital microfluidic devices for high protein content droplets transport |
GB2559216B (en) * | 2017-07-17 | 2019-02-06 | Acxel Tech Ltd | An electrowetting on dielectric droplet manipulation device |
US20190331639A1 (en) | 2018-04-25 | 2019-10-31 | Tecan Trading Ag | Cartridge, electrowetting sample processing system and droplet formation |
CN108970657B (zh) * | 2018-07-24 | 2021-04-13 | 北京机械设备研究所 | 一种微流体阵列控制器的制备方法 |
CN109261234B (zh) * | 2018-11-23 | 2021-03-23 | 京东方科技集团股份有限公司 | 微流控芯片和分析装置 |
CN109999929B (zh) * | 2019-03-28 | 2021-04-30 | 上海天马微电子有限公司 | 微流控装置及其驱动方法 |
WO2020259815A1 (en) | 2019-06-26 | 2020-12-30 | Tecan Trading Ag | Cartridge, electrowetting sample processing system and droplet formation |
CN110374963B (zh) * | 2019-07-01 | 2020-11-03 | 大连理工大学 | 一种可实现液体长距离自驱动运输的结构 |
CN110882729A (zh) * | 2019-09-30 | 2020-03-17 | 浙江大学 | 基于聚合物复合膜快速制备单层dmf芯片及制备方法 |
CN112675798B (zh) * | 2020-12-14 | 2022-11-08 | 上海天马微电子有限公司 | 微流体反应装置及微流体反应驱动方法 |
CN114653410B (zh) * | 2020-12-24 | 2023-07-14 | 广东奥素液芯微纳科技有限公司 | 一种微液滴生成方法及*** |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486337A (en) | 1994-02-18 | 1996-01-23 | General Atomics | Device for electrostatic manipulation of droplets |
US6565727B1 (en) | 1999-01-25 | 2003-05-20 | Nanolytics, Inc. | Actuators for microfluidics without moving parts |
US6911132B2 (en) | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
US8349276B2 (en) * | 2002-09-24 | 2013-01-08 | Duke University | Apparatuses and methods for manipulating droplets on a printed circuit board |
EP2346777A4 (de) | 2008-10-10 | 2014-10-01 | Univ Toronto | Hybride digitale mikrofluidische kanalvorrichtungen und herstellungsverfahren dafür |
CH700127A1 (de) * | 2008-12-17 | 2010-06-30 | Tecan Trading Ag | System und Vorrichtung zur Aufarbeitung biologischer Proben und zur Manipulation von Flüssigkeiten mit biologischen Proben. |
WO2011002957A2 (en) | 2009-07-01 | 2011-01-06 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods |
US8815070B2 (en) * | 2010-03-09 | 2014-08-26 | Sparkle Power, Inc. | Microelectrode array architecture |
WO2011126892A2 (en) * | 2010-03-30 | 2011-10-13 | Advanced Liquid Logic, Inc. | Droplet operations platform |
CN102671722B (zh) * | 2011-02-17 | 2015-03-11 | 王崇智 | 基于微电极阵列结构的现场可编程芯片实验室 |
US8470153B2 (en) * | 2011-07-22 | 2013-06-25 | Tecan Trading Ag | Cartridge and system for manipulating samples in liquid droplets |
-
2013
- 2013-09-23 WO PCT/EP2013/069703 patent/WO2014135232A1/en active Application Filing
- 2013-09-23 EP EP13770655.2A patent/EP2931425B1/de active Active
- 2013-09-23 CN CN201380074039.1A patent/CN105008052B/zh active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2014135232A1 * |
Also Published As
Publication number | Publication date |
---|---|
CN105008052B (zh) | 2018-09-14 |
EP2931425B1 (de) | 2021-03-24 |
CN105008052A (zh) | 2015-10-28 |
WO2014135232A1 (en) | 2014-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9120096B2 (en) | Manipulating the size of liquid droplets in digital microfluidics | |
EP2931425B1 (de) | Handhabung der grösse von flüssigkeitstropfen in digitalen mikrofluiden | |
US10252261B2 (en) | Handling liquid samples | |
JP5893620B2 (ja) | 合成液体セル | |
US8741661B2 (en) | Methods and devices for sampling flowable materials | |
EP3311919B1 (de) | Extraktion von flüssigkeit aus einer mikrofluidischen vorrichtung | |
JP4307074B2 (ja) | 生物学的、化学的または生化学的プロトコルを連続フローで実行するための方法及びシステム | |
US20200055053A1 (en) | Apparatuses and Methods for Operating a Digital Microfluidic Device | |
WO2023137139A2 (en) | Mechanical microfluidic manipulation | |
US20210205813A1 (en) | Contactless liquid loading to microfluidic devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150608 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20181005 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200508 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
INTC | Intention to grant announced (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20201019 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MAMONE, JOSEPH Inventor name: FRANKLIN, MICHAEL BENJAMIN Inventor name: LEE, TIMOTHY FRANCIS Inventor name: FEIGLIN, MARC N. |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1373948 Country of ref document: AT Kind code of ref document: T Effective date: 20210415 Ref country code: DE Ref legal event code: R096 Ref document number: 602013076451 Country of ref document: DE Ref country code: CH Ref legal event code: NV Representative=s name: TROESCH SCHEIDEGGER WERNER AG, CH |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210625 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210624 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210624 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20210324 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1373948 Country of ref document: AT Kind code of ref document: T Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210724 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210726 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013076451 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
26N | No opposition filed |
Effective date: 20220104 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210724 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210923 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210923 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130923 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230803 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230808 Year of fee payment: 11 Ref country code: DE Payment date: 20230802 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20231001 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210324 |